Filter by
Filter by
Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry.
A paper by MGH published in the Green Journal evaluated the factors that affect maximum follow-up time among MGH Pediatric Proton Consortium Registry (PPCR)...
Increased Risk of Pseudoprogression among Pediatric Low-Grade Glioma Patients Treated with Proton vs Photon Radiotherapy.
Pseudoprogression (PsP) is a recognized phenomenon after radiotherapy (RT) for glioma. This study evaluated 83 pediatric low-grade glioma (LGG) patients treated...